| Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer | |
| Sun, Yu-Lin; Cai, Jian-Qiang; Liu, Fang; Bi, Xin-Yu; Zhou, Lan-Ping; Zhao, Xiao-Hang | |
| 2015 | |
| 卷号 | 21期号:38页码:10840-10852 |
| 关键词 | Peroxiredoxin 1 Liver cancer Prognostic factor Post-translational modification SUMOylation |
| ISSN号 | 1007-9327 |
| DOI | 10.3748/wjg.v21.i38.10840 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6663491 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Sun, Yu-Lin,Cai, Jian-Qiang,Liu, Fang,et al. Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer[J],2015,21(38):10840-10852. |
| APA | Sun, Yu-Lin,Cai, Jian-Qiang,Liu, Fang,Bi, Xin-Yu,Zhou, Lan-Ping,&Zhao, Xiao-Hang.(2015).Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.,21(38),10840-10852. |
| MLA | Sun, Yu-Lin,et al."Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer".21.38(2015):10840-10852. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论